UnknownNot Applicable

Endoscopic Transfer of Flexor Hallucis Longus Tendon for Chronic Achilles Tendon Rupture

Norway38 participantsStarted 2015-12

Plain-language summary

The transfer of Flexor Hallucis Longus (FHL) in the management of chronic Achilles tendon ruptures has demonstrated good functional outcome, but an extensive surgical field at a vulnerable location may lead to increased risk for soft tissue problems. The arthroscopic FHL transfer may reduce the risk for soft tissue problems. Functional outcome parameters are investigated, wound/soft tissue complications registered.

Who can participate

Age range30 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Chronic Achilles Tendon Rupture Exclusion Criteria: * Pregnancy * BMI\<18.5 or \>39.9 * Insufficient Norwegian Language proficiency lack of communication skills local skin conditions at site for planned surgery

What they're measuring

The Victorian Institute of Sports Assessment- Achilles Questionnaire (VISA-A) outcome score

Timeframe: one year after FHL transfer

Trial details

NCT IDNCT02996253

SponsorOslo University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-02

View on ClinicalTrials.gov More Achilles Tendon Rupture trials